Canada Pension Plan Investment Board
MLYS icon

Canada Pension Plan Investment Board’s Mineralys Therapeutics MLYS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio MLYS Stock Details MLYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.39M Hold
51,400
– – ﹤0.01% 957
2026
Q1 		$1.39M Buy
51,400
+21,800
+74% +$639K ﹤0.01% 955
2025
Q4 		$1.07M Buy
+29,600
New +$1.19M ﹤0.01% 1053
2025
Q2 		– Sell
-279,500
Closed -$4.44M – 1420
2025
Q1 		$4.44M Buy
+279,500
New +$3.21M ﹤0.01% 703

Other funds holding MLYS

CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Canada Pension Plan Investment Board's MLYS Position: Q2 2026 in Review

Canada Pension Plan Investment Board held its Mineralys Therapeutics (MLYS) position steady in Q2 2026 at 51,400 shares worth $1.39M. The position accounts for ﹤0.01% of the portfolio, ranked #957.

Canada Pension Plan Investment Board first reported a position in MLYS in Q1 2025 and has held it in 4 quarters since. The position peaked at $4.44M in Q1 2025. 226 funds tracked by Wall St. Rank hold MLYS as of Q2 2026.

  • Canada Pension Plan Investment Board held 51,400 shares of Mineralys Therapeutics worth $1.39M as of Q2 2026.
  • Canada Pension Plan Investment Board left its Mineralys Therapeutics share count unchanged in Q2 2026.
  • Mineralys Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #957 holding.
  • Canada Pension Plan Investment Board first reported a position in Mineralys Therapeutics in Q1 2025 and has held it in 4 quarters since.
  • Canada Pension Plan Investment Board's Mineralys Therapeutics position peaked at $4.44M in Q1 2025.
  • 226 funds tracked by Wall St. Rank held Mineralys Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.